Kyeong Won Lee

Title: Kyeong Won Lee: Innovator in Fibroblast Growth Factor Research

Introduction

Kyeong Won Lee is a notable inventor based in Busan, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of fibroblast growth factors. With a total of 2 patents, his work focuses on enhancing the stability and efficacy of these important proteins.

Latest Patents

Kyeong Won Lee's latest patents include a polypeptide with improved temperature stability and protease resistance. This polypeptide exhibits FGF2 activity and includes specific substitutions that enhance its properties. Additionally, he has developed a recombinant vector and method for producing fibroblast growth factor 19 (FGF19) with enhanced solubility. This innovative approach allows for the overexpression of FGF19 in a soluble state, which is crucial for various applications in research and medicine.

Career Highlights

Throughout his career, Kyeong Won Lee has worked at the Korea Institute of Ocean Science & Technology. His research has contributed to advancements in the understanding and application of fibroblast growth factors, which play a vital role in cell growth and development.

Collaborations

Kyeong Won Lee has collaborated with several professionals in his field, including Young Jun An and Jung-Hyun Lee. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Kyeong Won Lee's contributions to the field of biotechnology, particularly through his patents and collaborative efforts, highlight his role as an influential inventor. His work continues to impact the development of therapeutic proteins and their applications in medicine.